Suffolk Capital Management Stake in Ligand Pharmaceuticals Incorpo (LGND) Has Upped as Stock Rose; As Express Scripts Hldg Co (ESRX) Stock Price Declined, W-G Shaheen & Associates Dba Whitney & Co Has Increased Stake

April 17, 2018 - By Kurt Siggers

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Logo

Suffolk Capital Management Llc increased its stake in Ligand Pharmaceuticals Incorpo (LGND) by 40.57% based on its latest 2017Q4 regulatory filing with the SEC. Suffolk Capital Management Llc bought 2,385 shares as the company’s stock rose 20.51% while stock markets declined. The institutional investor held 8,264 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $1.13M, up from 5,879 at the end of the previous reported quarter. Suffolk Capital Management Llc who had been investing in Ligand Pharmaceuticals Incorpo for a number of months, seems to be bullish on the $3.60 billion market cap company. The stock increased 1.27% or $2.14 during the last trading session, reaching $169.79. About 40,367 shares traded. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has risen 53.11% since April 17, 2017 and is uptrending. It has outperformed by 41.56% the S&P500.

W-G Shaheen & Associates Dba Whitney & Co increased its stake in Express Scripts Hldg Co (ESRX) by 102.89% based on its latest 2017Q4 regulatory filing with the SEC. W-G Shaheen & Associates Dba Whitney & Co bought 57,814 shares as the company’s stock declined 5.58% with the market. The institutional investor held 114,005 shares of the medical and nursing services company at the end of 2017Q4, valued at $8.51 million, up from 56,191 at the end of the previous reported quarter. W-G Shaheen & Associates Dba Whitney & Co who had been investing in Express Scripts Hldg Co for a number of months, seems to be bullish on the $40.94B market cap company. The stock increased 1.28% or $0.92 during the last trading session, reaching $72.91. About 725,787 shares traded. Express Scripts Holding Company (NASDAQ:ESRX) has risen 8.93% since April 17, 2017 and is uptrending. It has underperformed by 2.62% the S&P500.

W-G Shaheen & Associates Dba Whitney & Co, which manages about $275.21 million and $345.28 million US Long portfolio, decreased its stake in Paychex Inc (NASDAQ:PAYX) by 5,413 shares to 148,391 shares, valued at $10.10 million in 2017Q4, according to the filing. It also reduced its holding in Abbvie Inc (NYSE:ABBV) by 6,105 shares in the quarter, leaving it with 110,741 shares, and cut its stake in At&T Inc (NYSE:T).

Investors sentiment increased to 0.69 in 2017 Q4. Its up 0.07, from 0.62 in 2017Q3. It is positive, as 68 investors sold ESRX shares while 407 reduced holdings. 111 funds opened positions while 216 raised stakes. 479.40 million shares or 1.52% less from 486.80 million shares in 2017Q3 were reported. Johnson Inv Counsel Inc has 12,276 shares for 0.02% of their portfolio. Adage Capital Prtnrs Group Ltd Company stated it has 0.15% in Express Scripts Holding Company (NASDAQ:ESRX). First State Bank Of Omaha accumulated 11,060 shares or 0.05% of the stock. Garde stated it has 0.05% in Express Scripts Holding Company (NASDAQ:ESRX). Nippon Life Global Investors Americas has 0.42% invested in Express Scripts Holding Company (NASDAQ:ESRX). Tiverton Asset Mgmt Ltd Limited Liability Company has invested 1.27% in Express Scripts Holding Company (NASDAQ:ESRX). The New York-based Tompkins Financial Corp has invested 0% in Express Scripts Holding Company (NASDAQ:ESRX). First Personal invested 0.01% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX). Victory Cap Management Inc has invested 0.02% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX). Rafferty Asset Management Lc reported 32,290 shares or 0.04% of all its holdings. Symons Cap Inc has invested 3.38% in Express Scripts Holding Company (NASDAQ:ESRX). Hikari Power Limited owns 1.19% invested in Express Scripts Holding Company (NASDAQ:ESRX) for 134,600 shares. The Michigan-based Financial Bank has invested 0.22% in Express Scripts Holding Company (NASDAQ:ESRX). 2,846 were reported by Bartlett And Lc. Moreover, Freestone Capital Ltd Llc has 1.1% invested in Express Scripts Holding Company (NASDAQ:ESRX).

Among 25 analysts covering Express Scripts (NASDAQ:ESRX), 8 have Buy rating, 3 Sell and 14 Hold. Therefore 32% are positive. Express Scripts had 66 analyst reports since July 30, 2015 according to SRatingsIntel. As per Wednesday, January 24, the company rating was maintained by Mizuho. The company was upgraded on Friday, December 15 by Robert W. Baird. Bernstein downgraded the stock to “Underperform” rating in Thursday, February 1 report. Morgan Stanley downgraded Express Scripts Holding Company (NASDAQ:ESRX) on Thursday, January 21 to “Equal-Weight” rating. The firm has “Market Perform” rating by Bernstein given on Monday, March 12. The stock of Express Scripts Holding Company (NASDAQ:ESRX) earned “Sell” rating by Bernstein on Tuesday, January 30. The company was maintained on Tuesday, January 9 by Robert W. Baird. Deutsche Bank upgraded Express Scripts Holding Company (NASDAQ:ESRX) rating on Friday, November 4. Deutsche Bank has “Hold” rating and $70 target. The firm has “Hold” rating by Needham given on Monday, October 2. Morgan Stanley maintained the shares of ESRX in report on Thursday, August 10 with “Underweight” rating.

Since December 20, 2017, it had 0 insider buys, and 12 selling transactions for $16.28 million activity. $126,956 worth of stock was sold by Sabba Stephen L on Wednesday, December 20. HIGGINS JOHN L sold $4.32 million worth of stock or 28,099 shares. 7,500 shares were sold by Aryeh Jason, worth $1.32M on Thursday, March 8. The insider LAMATTINA JOHN L sold 3,335 shares worth $536,604. $832,824 worth of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) shares were sold by FOEHR MATTHEW W. Davis Todd C sold $2.62 million worth of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) on Monday, February 26.

Suffolk Capital Management Llc, which manages about $1.92B and $770.38M US Long portfolio, decreased its stake in Zendesk Corp (NYSE:ZEN) by 12,724 shares to 30,742 shares, valued at $1.04 million in 2017Q4, according to the filing. It also reduced its holding in Xylem Inc. (NYSE:XYL) by 31,134 shares in the quarter, leaving it with 186,751 shares, and cut its stake in Home Bancshares Inc. (NASDAQ:HOMB).

Among 6 analysts covering Ligand Pharmaceuticals (NASDAQ:LGND), 5 have Buy rating, 1 Sell and 0 Hold. Therefore 83% are positive. Ligand Pharmaceuticals had 29 analyst reports since September 3, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, September 21 by Roth Capital. As per Friday, December 18, the company rating was maintained by TH Capital. The rating was maintained by H.C. Wainwright on Wednesday, October 18 with “Buy”. The stock of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) earned “Hold” rating by Deutsche Bank on Tuesday, August 8. H.C. Wainwright maintained it with “Buy” rating and $159 target in Thursday, November 9 report. The rating was maintained by Roth Capital with “Buy” on Thursday, November 19. Roth Capital maintained the stock with “Buy” rating in Friday, December 18 report. The company was maintained on Thursday, October 5 by H.C. Wainwright. Deutsche Bank downgraded the stock to “Sell” rating in Friday, August 5 report. Roth Capital maintained Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) on Thursday, September 3 with “Buy” rating.

Express Scripts Holding Company (NASDAQ:ESRX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: